# Neuraxial Pethidine After Lumbar Surgery Trial

> **NCT00163553** · PHASE3 · UNKNOWN · sponsor: **Austin Health** · enrollment: 60 (estimated)

## Conditions studied

- Sciatica

## Interventions

- **DRUG:** Pethidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00163553
- **Lead sponsor:** Austin Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163553, "Neuraxial Pethidine After Lumbar Surgery Trial". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00163553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*